FDA Finalizes Guidance On Benefit-Risk Uncertainty
Executive Summary
A new guidance document from the US agency attempts to make the process for weighing uncertainty in benefit-risk determinations more transparent and consistent.
You may also be interested in...
Global Medtech Guidance Tracker: August 2019
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty new guidance documents have been posted on the tracker since its last update.
FDA Guidance Mulls Uncertainty In Device Reviews
New draft guidelines from US FDA offer a framework on how the agency will review device applications that include some uncertainty as to the benefits and risks of the technology.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.